Selected Publications
Yu Kang MD, PhD, Benedicte Lefebvre MD, Ingrid Marti Pamies PhD, Saar I Gill MD, PhD, Abigail G. Doucette MPH, Srinivas Denduluri PhD, Amanda M. Smith MA, Shannon McCurdy MD, Selina Luger MD, Joseph Carver MD, Marielle Scherrer-Crosbie MD, PhD: Symptomatic Heart Failure and Clonal Hematopoiesis–Related Mutations in Patients With Acute Myeloid Leukemia The American Journal of Cardiology : 2024.
Pashna Munshi and Shannon R. McCurdy: Age Barriers in Allogeneic Hematopoietic Cell Transplantation: Raising the Silver Curtain American Journal of Hematology 99 (5): 922-937,2024.
Anand S Bhagwat, MD, PhD, Leonel Torres*, Olga Shestova, PhD*, Maksim Shestov*, Noelle V. Frey, MD, MS, Elizabeth O Hexner, MD, MSTR, Selina M Luger, MD, FRCPC, Alison W Loren, MD, Mary Ellen Martin, MD, Shannon R McCurdy, MD, Alexander Perl, Edward A. Stadtmauer, MD, James K. Mangan, MD, Jennifer Brogdon, PhD, Joseph A Fraietta, PhD*, Wei-Ting Hwang, PhD*, Don L. Siegel, MD, PhD, Saad S. Kenderian, MD, David L. Porter, MD, Carl June, MD and Saar Gill, MD, PhD: Cytokine Release Syndrome Results in Reduced AML Killing By CD123 CAR T Cells Oral Abstract at the American Society of Hematology Annual Meeting : 2023.
Ashley D. Hadjis and Shannon R. McCurdy: The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation Frontiers in Immunology
15 : 2024.
Matthew P Connor, MD1, Neeharika Prathapa, MBBS1*, Noelle V. Frey, MD, MS1, Saar Gill, MD, PhD1, Elizabeth O Hexner, MD, MSTR1, Ximena Jordan Bruno, MD1, Catherine Lai, MD1, Alison W Loren, MD1, Selina M Luger, MD, FRCPC1, Andrew H Matthews, MD1*, Shannon R McCurdy, MD1, Alexander Perl1, David L. Porter, MD1, Arlene Zeringue2*, Joseph H. Oved, MD3, 4, Timothy S Olson, MD, PhD4, 5, Keith W Pratz, MD1 and Daria V Babushok, MD, PhD1, 4: Hypomethylating Agents Are Associated with High Rates of Hematologic Toxicity in Patients with Secondary MDS/AML That Develops after Acquired Aplastic Anemia American Society of Hematology, Annual Meeting : 2023.
Jeremy Schmoyer, Ashley D. Hadjis, Griffin W. White, Catherine Lai, and Shannon R. McCurdy: Association of Fried’s frailty phenotype, but not the clinical frailty scale, with overall survival in older adults with acute myeloid leukemia. American Society of Clinical Oncology 42 (16): 2024.
Ashley D Hadjis, MD*, Griffin W White*, Christopher Catania*, Noelle V. Frey, MD, MS, Saar Gill, MD, PhD, Elizabeth O Hexner, MD, MSTR, Ximena Jordan Bruno, MD, Catherine Lai, MD, Andrew H Matthews, MD*, Mary Ellen Martin, MD, Daria V Babushok, MD, PhD, Alexander Perl, David L. Porter, MD, Alison W Loren, MD, Keith W Pratz, MD, Selina M Luger, MD, FRCPC and Shannon R McCurdy, MD: Frail and Pre-Frail Older Adults with Acute Myeloid Leukemia Have Inferior Survival Due to Higher Rates of Disease-Related Deaths Oral Abstract at the American Society of Hematology Annual Meeting : 2023.
Brendan L. Mangan, PharmD, Clark DuMontier, MD, Judith O. Hopkins, MD, Gregory A. Abel, MD, and Shannon R. McCurdy, MD: Tailoring Therapy in Older Adults with Hematologic Malignancies American Society of Clinical Oncology, Education Book 44 (3): 2024.
Margaret Rowe, MD1*, Daria V Babushok, MD, PhD2, Martin Carroll, MD3, Alison Carulli, PharmD1*, Noelle V. Frey, MD, MS4, Saar Gill, MD, PhD4, Elizabeth O Hexner, MD, MSTR4, Rebecca Hirsh, MD1*, Nasheed Hossain, MD5*, Catherine Lai, MD4, Alison W Loren, MD4, Selina M Luger, MD, FRCPC6, Ivan Maillard4, Shannon R McCurdy, MD4, Andrew H Matthews, MD4*, Mary Ellen Martin, MD4, Vikram R Paralkar, MD4, Alexander Perl4, David L. Porter, MD7, Keith W Pratz, MD4, 5, Edward A. Stadtmauer, MD8 and Ximena Jordan Bruno, MD4: Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience American Society of Hematology Annual Meeting : 2023.
Takeshi Onoue, Azin Vakilpour, Yu Kang, Benedicte Lefebvre, Amanda Smith, Shannon R. McCurdy, Joseph R. Carver, Michael Fradley, Jesse Chittams, and Marielle Scherrer-Crosbie: Cardiotoxicity of Venetoclax in Patients with Acute Myeloid Leukemia: Comparison with Anthracyclines Journal of the American College of Cardiology 83 (13): 2024.
Seiichi Villalona, MD, MA1*, Xin Wang, MD2, Peter Gabriel, MD3*, Abigail Doucette4*, Shannon R McCurdy, MD2, Alexander Perl2, Selina M Luger, MD, FRCPC2, Noelle V. Frey, MD, MS2, Ximena Jordan Bruno, MD2, Elizabeth O Hexner, MD, MSTR2, Daria V Babushok, MD, PhD5, David L. Porter, MD2, Alison W Loren, MD2, Keith W Pratz, MD2 and Catherine Lai, MD: Patient-Reported Outcome Measures Associated with Overall Survival and Acute Care Use in Patients with Newly Diagnosed Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Acute Lymphoblastic Leukemia American Society of Hematology Annual Meeting : 2023.
Anthony D. Sung, Thuy Koll, Shannon H. Gier, Alessandro Racioppi, Griffin White, Meagan Lew, Marcia Free, Priyal Agarwal, Lauren M. Bohannon, Ernaya J. Johnson, Bharathi Selvan, Daria V. Babushok, Noelle V. Frey, Saar I. Gill, Elizabeth O. Hexner, MaryEllen Martin, Alexander E. Perl, Keith W. Pratz, Selina M. Luger, Nelson J. Chao, Shannon R. McCurdy: Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients Transplantation and Cellular Therapy 30 (4): 2024.
Xin Wang, MD1, Phyllis Gimotty, PhD2*, Andrew H Matthews, MD1*, Ronac Mamtani, MD, MSCE1*, Selina M Luger, MD, FRCPC1, Elizabeth O Hexner, MD, MSTR1, Daria V Babushok, MD, PhD1, Shannon R McCurdy, MD1, Noelle V. Frey, MD, MS1, Ximena Jordan Bruno, MD1, David L. Porter, MD1, Saar Gill, MD, PhD1, Mary Ellen Martin, MD1, Vikram R Paralkar, MD1, Ivan Maillard1, Alison W Loren, MD1, Alexander Perl1, Keith W Pratz, MD1, Kelly D. Getz, PhD, MPH2, 3* and Catherine Lai, MD1: Evolving Racial/Ethnic Disparities in AML Survival in the Novel Therapy Era: Real-World Evidence of Improved Survival in Older Patients with the Largest Improvement in Non-Hispanic Black Patients Oral Abstract at the American Society of Hematology Annual Meetings : 2023.
Shannon R. McCurdy, Scott R. Solomon, Brian C. Shaffer, Meilun He, Yung-Tsi Bolon, Amanda G. Blouin, Alla Keyzner, Francisco A. Socola, Uroosa Ibrahim, Jun Zou, Hana Safah, Nakhle Saba, Shahinaz Gadalla, Miguel-Angel Perales, Sophie Paczesny, Steven Marsh, Effie W. Petersdorf, Tao Wang, Ephraim J. Fuchs, Stephanie J. Lee: Post-Transplantation Cyclophosphamide Improves Graft-Versus-Host Disease-Free, Relapse-Free Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplant
European Society of Blood and Marrow Transplantation Annual Meeting : B004,2024.
Andrew Artz, MD, MS, Brent R. Logan, PhD*, Wael Saber, MD, MS, Nancy Geller, PhD*, Anna Bellach, Ph.D.*, Jianqun Kou, MS*, William Wood, MD, MPH, John M. McCarty, MD, Thomas G. Knight, MD, Lyndsey Runaas*, Laura Johnston, Jeremy Walston*, Ryotaro Nakamura, MD, Tammy Schuler*, Asmita Mishra, MD, MBA, Joseph Uberti, MD, PhD, Parastoo B. Dahi, MD*, Jennifer N. Saultz, DO, Shannon R. McCurdy, MD, Lawrence Morris, MD, Philip Imus, MD, William J. Hogan, MD, Kalyan Nadiminti, MBBS, Vijaya Raj Bhatt, MD, Deborah Mattila, BA*, Bailey Protz*, Steven M. Devine, MD, Mary M. Horowitz, MD and Mohamed Sorror, MD, MSc: The Composite Health Risk Assessment Model (CHARM) to Predict 1-year Non-relapse Mortality (NRM) among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704 Oral Abstract American Society of Hematology Annual Meeting
: 2023.
Matthew P. Connor, Neeharika Prathapa, Noelle V. Frey, Saar I. Gill, Elizabeth O. Hexner, Ximena Jordan Bruno, Catherine E. Lai, Alison W. Loren, Selina M. Luger, Andrew H. Matthews, Shannon R. McCurdy, Alexander E Perl, David L. Porter, Arlene Zeringue, Joseph H. Oved, Timothy S. Olson, Keith W. Pratz, Daria V. Babushok: Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Haematologica : 2024.
Ashley D. Hadjis and Shannon R. McCurdy: Post-Transplantation Cyclophosphamide: Changing the Paradigm of HLA-Mismatching American Society of Histocompatibility and Immunogenetics 47 (3): 13-20,2023.
Mustafa A. Hyder, Shannon R. McCurdy, Ruby Sabina, Ashley DeVries, Kirstin Chalupa, Natasha Berryman, Jessica Bernhardt, Alison Cusmano, Amy Chai, Rebecca Schwartz, Dimana Dimitrova, Kamil Rechache, Christi McKeown, Jennifer Sponaugle, Noelle Frey, Saar Gill, Elizabeth O. Hexner, Maryellen Martin, Nasheed Hossain, David L. Porter, Alison W. Loren, Jennifer A. Kanakry, Christopher G. Kanakry: Interim Results of a Phase I/II Study of Intermediate-Dose Post-Transplantation Cyclophosphamide after Reduced Intensity Conditioned HLA-Matched Bone Marrow Transplantation for Older or Infirm Patients Transplantation and Cellular Therapy, Tandem Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and the CIBMTR : 2024.
Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall S, Gondek L, Bashey A, Keyzner A, Tamari R, Grunwald M, Abedin S, Nadiminti K, Iqbal M, Gerds A, Viswabandya A, McCurdy S, Malki MA, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S.: Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration Haematologica : 2023.
View all publications
Academic Contact Information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12 South Pavilion
Philadelphia,
PA
19104
Patient appointments: 800-789-7366